Literature DB >> 18826840

Murine typhus and febrile illness, Nepal.

Mark D Zimmerman1, David R Murdoch, Patrick J Rozmajzl, Buddha Basnyat, Christopher W Woods, Allen L Richards, Ram Hari Belbase, David A Hammer, Trevor P Anderson, L Barth Reller.   

Abstract

Murine typhus was diagnosed by PCR in 50 (7%) of 756 adults with febrile illness seeking treatment at Patan Hospital in Kathmandu, Nepal. Of patients with murine typhus, 64% were women, 86% were residents of Kathmandu, and 90% were unwell during the winter. No characteristics clearly distinguished typhus patients from those with blood culture-positive enteric fever.

Entities:  

Mesh:

Year:  2008        PMID: 18826840      PMCID: PMC2609894          DOI: 10.3201/eid1410.080236

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


In 2001, we found Salmonella enterica serotype Typhi and S. enterica serotype Paratyphi A to be the most common causes of bloodstream infections among adults with febrile illness who sought treatment at Patan Hospital in Kathmandu, Nepal (). Another important finding was the relatively high percentage of patients (11%) who had immunoglobulin (Ig) M antibodies against Rickettsia typhi in peripheral blood. Because most testing was performed on unpaired acute-phase sera, and a high percentage of seropositive results were found in a group of healthy study participants, we were uncertain whether these participants had acute murine typhus or more distant past infection. Recent studies have shown the value of PCR for diagnosing scrub typhus (–), and a real-time assay for R. typhi has recently been validated (). In our study, we tested archived blood samples from our febrile adult cohort () with this R. typhi PCR to better characterize the incidence of murine typhus and to determine whether clinical features could help distinguish murine typhus from enteric (typhoid) fever.

The Study

We studied consecutive adult patients with fever (axillary temperature >38°C; >13 years of age) who sought treatment at Patan Hospital from January 15 through March 15, 2001 (winter) and July 2 through August 10, 2001 (summer), as detailed elsewhere (). The study was approved by the Nepal Health Research Council and the Institutional Review Board of the Centers for Disease Control and Prevention. Blood from each patient was injected into blood culture bottles and serum samples were tested for R. typhi IgM antibodies (INDX Multi-Test Dip-S-Ticks SDLST; Integrated Diagnostics, Inc., Baltimore, MD, USA). In addition, whole blood samples (stored at −80ºC) were tested by real-time PCR for R. typhi at the Naval Medical Research Center, Silver Spring, MD (NMRC) and at Canterbury Health Laboratories, Christchurch, New Zealand (CHL). Details of the assay have been described elsewhere (). We extracted DNA from 200 μL of whole blood and used primers and probes specific to a portion of the outer membrane protein B (ompB) unique to R. typhi to amplify and detect the target sequence in a SmartCycler (Cepheid, Sunnyvale, CA, USA) at NMRC and in a LightCycler (Roche Diagnostics, Mannheim, Germany) thermocycler at CHL. Thermocycling parameters included an initial denaturation step (2 min at 9°C) followed by 45 cycles of denaturation (94°C for 5 s) and annealing/elongation (60°C for 30 s) steps. Positive samples were defined as those that demonstrated fluorescence above background levels. Template-free controls assayed at the same time and under the same conditions as the experimental and positive control samples consistently showed negative results. In our study, a diagnosis of murine typhus required a positive R. typhi PCR result; a diagnosis of enteric fever required a positive blood culture for S. Typhi or S. Paratyphi. Data from patients with murine typhus were compared with those from patients with enteric fever by using the χ2 test or Fisher exact test for dichotomous and ordinal variables, and 2-sided Wilcoxon rank sum test and the Student t test for continuous variables. We used multivariable logistic regression analysis to further evaluate variables associated with murine typhus. Murine typhus was the outcome variable in the final model; other variables were those associated with the outcome with p<0.1 on bivariable analysis. Data were analyzed by using STATA version 8.2 (StataCorp, College Station, TX, USA). We enrolled 876 patients, 370 in winter and 506 in summer. In 323 (37%) patients, a putative diagnosis was established; 117 (13%) patients had positive blood cultures for S. Typhi or S. Paratyphi A. Whole blood samples were available for testing from 756 (86%) patients. Of these patients, 85 (11%) had R. typhi IgM antibodies detected in acute-phase serum samples and 50 (7%) had positive R. typhi PCR results; 11 (13%) of the R. typhi–seropositive patients were also PCR positive. Sequencing of amplicons from 5 PCR-positive patients showed 100% similarity with the reference strain of R. typhi (GenBank accession no. AE017197). None of the patients with positive PCR results for R. typhi had a positive blood culture. The features of the 50 patients with murine typhus and the 94 patients with enteric fever are presented in the Table; all had negative R. typhi PCR results. Sixteen of the murine typhus patients had chest radiographs; 6 (38%) of these patients were reported as having lung infiltrates. Of the 50 patients with murine typhus, 45 were managed as outpatients and 5 were ill enough to be admitted to a hospital. No deaths occurred.
Table

Demographic, clinical, and laboratory features of patients with murine typhus and enteric fever, Nepal*

VariableMurine typhus, n = 50Enteric fever, n = 94p value
Demographics
Age, y, median (range)28 (15–85)22 (14–72)0.0001
Male gender
18 (36)
61 (65)
0.001
Occupation0.001
Housewife
17 (41)
10 (12)

Student
7 (17)
36 (42)

Business person2 (5)7 (8)
Government employee2 (5)8 (9)
Other
13 (32)
24 (28)

Residence


<0.001
Kathmandu
31 (86)
27 (32)

Patan028 (33)
Kathmandu Valley4 (11)10 (12)
Other
1 (3)
20 (24)

Winter season
45 (90)
27 (29)
<0.001
Admission diagnosis<0.001
Enteric fever21 (42)66 (70)
Lower respiratory tract infection13 (26)3 (3)
Urinary tract infection6 (12)3 (3)
Upper respiratory tract infection3 (6)1 (1)
Other
7 (14)
21 (22)

Symptoms
Cough33 (66)30 (33)<0.001
Shortness of breath16 (32)6 (7)<0.001
Nausea14 (28)34 (37)0.26
Diarrhea5 (10)16 (18)0.24
Abdominal pain16 (33)25 (28)0.58
Headache41 (82)78 (86)0.56
Joint pain12 (24)11 (12)0.07
Duration of symptoms, d, median (range)
5 (1–10)
5 (1–30)
0.23
Examination findings
Temperature, °C, mean (SD)38.9 (0.7)38.8 (0.6)0.54
Respiratory rate, breaths/min, mean (SD)26 (9)21 (5)0.0002
Heart rate, beats/min, mean (SD)112 (17)105 (15)0.02
Systolic blood pressure, mm Hg, mean (SD)109 (17)107 (11)0.52
Diastolic blood pressure, mm Hg, mean (SD)70 (10)70 (8)0.88
Crackles
13 (26)
8 (9)
0.006
Hepatomegaly2 (4)9 (10)0.22
Splenomegaly2 (4)12 (13)0.09
Rash
0
1 (1)
0.46
Laboratory findings
Hematocrit, %, mean (SD)39 (6)39 (5)0.70
Leukocyte count, cells × 109/L, median (IQR)8.9 (6.2–11.1)5.8 (4.8–7.6)<0.001
Neutrophils, %, median (IQR)83 (74–87)68 (60–73)<0.001
Lymphocytes, %, median (IQR)13 (9–22)27 (20–35)<0.001
Monocytes, %, median (IQR)2.5 (1–5)2 (0–4)0.57
Eosinophils, %, median (IQR)0.5 (0–2)0 (0–2)0.80

*Data are no. (%) unless otherwise stated. SD, standard deviation; IQR, interquartile range.

*Data are no. (%) unless otherwise stated. SD, standard deviation; IQR, interquartile range. After logistic regression analysis, only 3 variables were significantly associated with murine typhus compared with enteric fever. These variables were age (for each increase by 1 year) (odds ratio [OR) 1.07, 95% confidence interval [CI] 1.00–1.16, p = 0.05); Kathmandu residence (OR 14.37, 95% CI 1.07–193.39, p = 0.05); and winter season (OR 28.93, 95% CI 2.47–338.93, p = 0.007).

Conclusions

We detected R. typhi DNA in blood from 7% of the febrile adult study population from urban Nepal. This finding is likely to be an underestimate of the actual extent of rickettsial disease because of the small volume of blood tested in each PCR and possible sample deterioration during transport and storage (between sample collection and testing). Although PCR has yet to be extensively evaluated for the diagnosis of murine typhus (–), a sizeable body of evidence supports the high sensitivity and specificity of PCR for the diagnosis of rickettsial diseases (,,,). The real-time PCR used in our study has a high analytical sensitivity and specificity for R. typhi (), and sequencing of amplicons from our patients further supports the specificity of the assay. In addition, none of our patients with murine typhus had positive blood cultures. The results of this and other (,) studies indicate that murine typhus is an important endemic infection in Nepal. Although our study did not extend throughout the full year, murine typhus was more common in winter than in summer. This finding contrasts with the summer–autumn predominance reported in other regions (,). We also noted a clear predominance of cases from Kathmandu and none from the Patan side of the city, despite the fact that the latter is the main catchment area for Patan Hospital. It is possible that an outbreak of murine typhus occurred in Kathmandu during the winter of 2001, and epidemiologic studies are needed to clarify whether there is a focus of murine typhus activity in Kathmandu. In Nepal, enteric fever is one of the most common causes of febrile illness (,). We identified no reliable clinical marker to distinguish murine typhus from enteric fever, and the classic clinical triad of rickettsial diseases (headache, fever, and rash) was not detected in any of our patients. Murine typhus should be considered as an alternative diagnosis in patients with suspected enteric fever in Nepal. This diagnosis is especially important given that first-line antimicrobial drug therapy is different for the 2 diseases. Our study highlights the importance of rickettsial infections as a cause of febrile illness in Kathmandu. Further epidemiologic and ecologic studies are needed to better clarify the features of murine typhus in Nepal.
  15 in total

1.  Murine typhus as a common cause of fever of intermediate duration: a 17-year study in the south of Spain.

Authors:  M Bernabeu-Wittel; J Pachón; A Alarcón; L F López-Cortés; P Viciana; M E Jiménez-Mejías; J L Villanueva; R Torronteras; F J Caballero-Granado
Journal:  Arch Intern Med       Date:  1999-04-26

2.  Development of quantitative real-time PCR assays to detect Rickettsia typhi and Rickettsia felis, the causative agents of murine typhus and flea-borne spotted fever.

Authors:  Katherine M Henry; Ju Jiang; Patrick J Rozmajzl; Abdu F Azad; Kevin R Macaluso; Allen L Richards
Journal:  Mol Cell Probes       Date:  2006-07-01       Impact factor: 2.365

3.  Clinical usefulness of eschar polymerase chain reaction for the diagnosis of scrub typhus: a prospective study.

Authors:  Dong-Min Kim; Hyun Lee Kim; Chi Young Park; Tae Young Yang; Ji Hyun Lee; Jong Tae Yang; Soo-Kyoung Shim; Seung-Hyun Lee
Journal:  Clin Infect Dis       Date:  2006-10-12       Impact factor: 9.079

4.  Antibodies to typhus in Eastern Nepal.

Authors:  G W Brown; A Shirai; E Gan; P Bernthal
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

5.  Usefulness of nested PCR for the diagnosis of scrub typhus in clinical practice: A prospective study.

Authors:  Dong-Min Kim; Na Ra Yun; Tae Young Yang; Ji Hyun Lee; Jong Tae Yang; Soo-Kyoung Shim; Eun-Na Choi; Mi-Yeoun Park; Seung-Hyun Lee
Journal:  Am J Trop Med Hyg       Date:  2006-09       Impact factor: 2.345

6.  A highly sensitive and specific real-time PCR assay for the detection of spotted fever and typhus group Rickettsiae.

Authors:  John Stenos; Stephen R Graves; Nathan B Unsworth
Journal:  Am J Trop Med Hyg       Date:  2005-12       Impact factor: 2.345

7.  Short report: detection of Orientia tsutsugamushi in clinical samples by quantitative real-time polymerase chain reaction.

Authors:  Tasawan Singhsilarak; Wattana Leowattana; Sornchai Looareesuwan; Varee Wongchotigul; Ju Jiang; Allen L Richards; George Watt
Journal:  Am J Trop Med Hyg       Date:  2005-05       Impact factor: 2.345

8.  Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal.

Authors:  Ashish P Maskey; Jeremy N Day; Quoc Tuan Phung; Guy E Thwaites; James I Campbell; Mark Zimmerman; Jeremy J Farrar; Buddha Basnyat
Journal:  Clin Infect Dis       Date:  2006-03-29       Impact factor: 9.079

9.  Identification of a novel rickettsial infection in a patient diagnosed with murine typhus.

Authors:  M E Schriefer; J B Sacci; J S Dumler; M G Bullen; A F Azad
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

10.  The etiology of febrile illness in adults presenting to Patan hospital in Kathmandu, Nepal.

Authors:  David R Murdoch; Christopher W Woods; Mark D Zimmerman; Peter M Dull; Ram Hari Belbase; Andrew J Keenan; Robert Mcnair Scott; Buddha Basnyat; Lennox K Archibald; L Barth Reller
Journal:  Am J Trop Med Hyg       Date:  2004-06       Impact factor: 2.345

View more
  20 in total

1.  Rickettsia typhi infection with interstitial pneumonia in a traveler treated with moxifloxacin.

Authors:  Marco H Schulze; Christian Keller; Andreas Müller; Uwe Ziegler; Heinz-Jakob Langen; Guido Hegasy; August Stich
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

Review 2.  Searching for the elusive typhoid diagnostic.

Authors:  Stephen Baker; Michael Favorov; Gordon Dougan
Journal:  BMC Infect Dis       Date:  2010-03-05       Impact factor: 3.090

3.  An Unusual Cutaneous Manifestation in a Patient with Murine Typhus.

Authors:  Lucas S Blanton; Alfred S Lea; Brent C Kelly; David H Walker
Journal:  Am J Trop Med Hyg       Date:  2015-09-28       Impact factor: 2.345

4.  Analysis of Health-Care Charges in Murine Typhus: Need for Improved Clinical Recognition and Diagnostics for Acute Disease.

Authors:  Rahat F Vohra; David H Walker; Lucas S Blanton
Journal:  Am J Trop Med Hyg       Date:  2018-04-05       Impact factor: 2.345

5.  Combined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmission.

Authors:  Stephen Baker; Kathryn E Holt; Archie C A Clements; Abhilasha Karkey; Amit Arjyal; Maciej F Boni; Sabina Dongol; Naomi Hammond; Samir Koirala; Pham Thanh Duy; Tran Vu Thieu Nga; James I Campbell; Christiane Dolecek; Buddha Basnyat; Gordon Dougan; Jeremy J Farrar
Journal:  Open Biol       Date:  2011-10       Impact factor: 6.411

6.  Undifferentiated febrile illness in Kathmandu, Nepal.

Authors:  Corinne N Thompson; Stuart D Blacksell; Daniel H Paris; Amit Arjyal; Abhilasha Karkey; Sabina Dongol; Abhishek Giri; Christiane Dolecek; Nick Day; Stephen Baker; Guy Thwaites; Jeremy Farrar; Buddha Basnyat
Journal:  Am J Trop Med Hyg       Date:  2015-02-09       Impact factor: 2.345

7.  Murine typhus in child, Yucatan, Mexico.

Authors:  Jorge E Zavala-Castro; Jorge E Zavala-Velázquez; Justo Eduardo Sulú Uicab
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

8.  The sensitivity of real-time PCR amplification targeting invasive Salmonella serovars in biological specimens.

Authors:  Tran Vu Thieu Nga; Abhilasha Karkey; Sabina Dongol; Hang Nguyen Thuy; Sarah Dunstan; Kathryn Holt; Le Thi Phuong Tu; James I Campbell; Tran Thuy Chau; Nguyen Van Vinh Chau; Amit Arjyal; Samir Koirala; Buddha Basnyat; Christiane Dolecek; Jeremy Farrar; Stephen Baker
Journal:  BMC Infect Dis       Date:  2010-05-21       Impact factor: 3.090

9.  Seroprevalence and Clinical Features of Scrub Typhus among Febrile Patients Attending a Referral Hospital in Kathmandu, Nepal.

Authors:  Anil Pokhrel; Binod Rayamajhee; Saroj Khadka; Sandeep Thapa; Samjhana Kapali; Sher Bahadur Pun; Megha Raj Banjara; Prakash Joshi; Binod Lekhak; Komal Raj Rijal
Journal:  Trop Med Infect Dis       Date:  2021-05-13

10.  Bloodstream infection among children presenting to a general hospital outpatient clinic in urban Nepal.

Authors:  Rahul Pradhan; Umesh Shrestha; Samir C Gautam; Stephen Thorson; Kabindra Shrestha; Bharat K Yadav; Dominic F Kelly; Neelam Adhikari; Andrew J Pollard; David R Murdoch
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.